The CEO Roundtable on Cancer has accredited Focused Ultrasound Foundation in Charlottesville, VA, with the CEO Cancer Gold StandardTM, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited 3M Austin Center in Austin, TX with the CEO Cancer Gold Standard™ recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Cancer Gold Standard, the employer health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than 5 million employees and their family members prevent and address cancer through workplace-based programming as the first six Gold Standard employers celebrate ten years of accreditation.
The CEO Roundtable on Cancer has accredited Hatteras Venture Partners, an early-stage venture capital investment company in Durham, N.C., with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited The Ohio State University in Columbus, Ohio, with the CEO Cancer Gold Standard™, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer presented the Alliance for Clinical Trials in Oncology and Pfizer with the 2015 Dr. Charles A. Sanders Life Sciences Awards.
The CEO Roundtable on Cancer elected Robert A. Bradway as its Chairman at its recent annual meeting, CEO Roundtable-XIV.
CARY, NC (09/28/2015) Helsinn, a privately-owned pharmaceutical group with its headquarters in Lugano, Switzerland, has earned the prestigious Global CEO Cancer Gold StandardTM accreditation. This accreditation recognizes the Company’s worldwide commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring quality care, thereby improving quality of life and increasing productivity for employees around the globe.
CARY, N.C. (09/17/2015) The CEO Roundtable on Cancer has accredited ProMedica, a leading healthcare organization in northwest Ohio, with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
Project Data Sphere, LLC (PDS) is an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC). The CEO Roundtable on Cancer has expanded the executive leadership of PDS to continue building on PDS’s first-year data collection successes and broaden the academic, government and industry collaborations that continue to drive the progress of this innovative research library-laboratory.
CARY, N.C. (08/13/2015) The CEO Roundtable on Cancer has accredited PAREXEL International in Waltham, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
CARY, N.C. (07/08/2015) The CEO Roundtable on Cancer has accredited Quinnipiac University’s North Haven Campus in Connecticut with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
CARY, N.C. (06/24/2015) The CEO Roundtable on Cancer has accredited the School District of Palm Beach County in West Palm Beach, FL with the CEO Cancer Gold StandardTM recognizing the District’s efforts to reduce the risk of cancer for its employees and covered family members.
Cancer research platform sees intensive first-year data collection effort
followed by peer-reviewed research publication
CARY, NC (June 1, 2015) – Following its one-year launch anniversary and the achievement of its goal of including data from 25,000 patient lives, Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), marked the publication of several peer-reviewed articles using academic and industry cancer clinical trial data from this innovative research library-laboratory.
CARY, NC (May 11, 2015) – Since its launch one year ago, Project Data Sphere, LLC (PDS), an independent not-for-profit initiative of the CEO Roundtable on Cancer’s Life Sciences Consortium (LSC), achieved its key 12-month goal of including data from 25,000 patient lives as part of its broader aim to share, integrate and analyze historical patient level, comparator arm data from academic and industry cancer clinical trials to drive innovation and accelerate research. The broad-access approach of the Project Data Sphere® platform, www.ProjectDataSphere.org, is bringing together diverse minds and technology to help unleash the full potential of existing clinical trial data and speed innovation by generating collective insights that may lead to improved trial design, modeling of disease progression and endpoints and entirely new research gleaned from applying advanced analytic technology to existing data.
CARY, N.C. (04/06/2015) The CEO Roundtable on Cancer has accredited the Association of American Cancer Institutes (AACI) in Pittsburgh, PA with the CEO Cancer Gold StandardTM recognizing the association’s efforts to reduce the risk of cancer for its employees and covered family members.
CARY, NC (04/03/2015) The CEO Roundtable on Cancer proudly recognizes the State of Oklahoma as the first State in the country to earn CEO Cancer Gold StandardTM accreditation, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
CARY, N.C. (03/17/2015) The CEO Roundtable on Cancer has accredited AREVA Med with the CEO Cancer Gold StandardTM recognizing the company’s efforts to reduce the risk of cancer for its employees and covered family members.